(R)-N-Boc-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid, 95.0%, 500g

2-[5-amino-3-(2-furyl)-1H-pyrazol-1-yl]-6-propylpyrimidin-4(3H)-one, 95.0%, 250mg

3-Bromo-5-fluorobenzonitrile, 98.0%, 5g

(S)-5-(4-(3,5-Dimethylisoxazol-4-yl)-2-(pyrrolidin-3-yloxy)phenyl)-2-ureidothiophene-3-carboxamide, 98%, 50mg

2-(3-Fluoro-5-methylphenyl)acetic acid, 95.0%, 25g

3-Chloroimidazo[1,2-a]pyridin-6-amine, 97%, 250mg

Tetrakis(dimethylamino)ethylene>95.0%(GC)5g

Solución de eosina Y, 500 ml.

1H-3a,7-Methanoazulene, 2,3,4,7,8,8a-hexahydro-3,6,8,8-tetramethyl-,(3R,3aS,7S,8aS)-, 95%, 5g

3-(4-Iodophenyl)-1,2-oxazol-5-amine, 95%, 100mg

(S)-2-Amino-3-(4-sulfophenyl)propanoic acid, 95.0%, 250mg

(5E)-2-mercapto-5-(2-methylbenzylidene)-1,3-thiazol-4(5H)-one, 95.0%, 5g

3-Iodo-1,4-dimethyl-1H-pyrazole, 95.0%, 5g